Search research articles
Contact Us
Filters
Showing results (51-60 of 204) with videos related to
Page
of 21
Sort By:
Antimicrobial Agents and Chemotherapy
|
August 31, 2011
Fractal geometry and the pharmacometrics of micafungin in overweight, obese, and extremely obese people
Ronald G Hall, Mark A Swancutt, Tawanda Gumbo
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 16, 2016
Partnerships to Design Novel Regimens to Treat Childhood Tuberculosis, Sui Generis: The Road Ahead
Tawanda Gumbo, Mamodikoe K Makhene, James A Seddon
Pharmacotherapy
|
December 2, 2009
Treatment of active pulmonary tuberculosis in adults: current standards and recent advances. Insights from the Society of Infectious Diseases Pharmacists
Ronald G Hall, Richard D Leff, Tawanda Gumbo
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 30, 2018
Efficacy Versus Hepatotoxicity of High-dose Rifampin, Pyrazinamide, and Moxifloxacin to Shorten Tuberculosis Therapy Duration: There Is Still Fight in the Old Warriors Yet!
Shashikant Srivastava, Devyani Deshpande, Gesham Magombedze, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 1, 2017
Reply to Raoult
James A Seddon, Mamodikoe K Makhene, Tawanda Gumbo
Frontiers in Pharmacology
|
November 4, 2022
Minocycline intra-bacterial pharmacokinetic hysteresis as a basis for pharmacologic memory and a backbone for once-a-week pan-tuberculosis therapy
Devyani Deshpande, Shashikant Srivastava, Jotam Garaimunashe Pasipanodya, et al.
The Journal of Antimicrobial Chemotherapy
|
September 20, 2017
Linezolid as treatment for pulmonary Mycobacterium avium disease
Devyani Deshpande, Shashikant Srivastava, Jotam G Pasipanodya, et al.
Antimicrobial Agents and Chemotherapy
|
July 22, 2020
Comparison of a Novel Regimen of Rifapentine, Tedizolid, and Minocycline with Standard Regimens for Treatment of Pulmonary Mycobacterium kansasii
Moti Chapagain, Tawanda Gumbo, Scott K Heysell, et al.
Frontiers in Pharmacology
|
February 5, 2021
Tedizolid, Faropenem, and Moxifloxacin Combination With Potential Activity Against Nonreplicating <i>Mycobacterium tuberculosis</i>
Shashikant Srivastava, Kayle N Cirrincione, Devyani Deshpande, et al.
The Journal of Antimicrobial Chemotherapy
|
September 20, 2017
A 'shock and awe' thioridazine and moxifloxacin combination-based regimen for pulmonary Mycobacterium avium-intracellulare complex disease
Shashikant Srivastava, Devyani Deshpande, Carleton M Sherman, et al.
Page
of 21
Search research articles
Search
Showing results (51-60 of 204) with videos related to
Sort By:
Page
of 21
Antimicrobial Agents and Chemotherapy
|
August 31, 2011
Fractal geometry and the pharmacometrics of micafungin in overweight, obese, and extremely obese people
Ronald G Hall, Mark A Swancutt, Tawanda Gumbo
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 16, 2016
Partnerships to Design Novel Regimens to Treat Childhood Tuberculosis, Sui Generis: The Road Ahead
Tawanda Gumbo, Mamodikoe K Makhene, James A Seddon
Pharmacotherapy
|
December 2, 2009
Treatment of active pulmonary tuberculosis in adults: current standards and recent advances. Insights from the Society of Infectious Diseases Pharmacists
Ronald G Hall, Richard D Leff, Tawanda Gumbo
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 30, 2018
Efficacy Versus Hepatotoxicity of High-dose Rifampin, Pyrazinamide, and Moxifloxacin to Shorten Tuberculosis Therapy Duration: There Is Still Fight in the Old Warriors Yet!
Shashikant Srivastava, Devyani Deshpande, Gesham Magombedze, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 1, 2017
Reply to Raoult
James A Seddon, Mamodikoe K Makhene, Tawanda Gumbo
Frontiers in Pharmacology
|
November 4, 2022
Minocycline intra-bacterial pharmacokinetic hysteresis as a basis for pharmacologic memory and a backbone for once-a-week pan-tuberculosis therapy
Devyani Deshpande, Shashikant Srivastava, Jotam Garaimunashe Pasipanodya, et al.
The Journal of Antimicrobial Chemotherapy
|
September 20, 2017
Linezolid as treatment for pulmonary Mycobacterium avium disease
Devyani Deshpande, Shashikant Srivastava, Jotam G Pasipanodya, et al.
Antimicrobial Agents and Chemotherapy
|
July 22, 2020
Comparison of a Novel Regimen of Rifapentine, Tedizolid, and Minocycline with Standard Regimens for Treatment of Pulmonary Mycobacterium kansasii
Moti Chapagain, Tawanda Gumbo, Scott K Heysell, et al.
Frontiers in Pharmacology
|
February 5, 2021
Tedizolid, Faropenem, and Moxifloxacin Combination With Potential Activity Against Nonreplicating <i>Mycobacterium tuberculosis</i>
Shashikant Srivastava, Kayle N Cirrincione, Devyani Deshpande, et al.
The Journal of Antimicrobial Chemotherapy
|
September 20, 2017
A 'shock and awe' thioridazine and moxifloxacin combination-based regimen for pulmonary Mycobacterium avium-intracellulare complex disease
Shashikant Srivastava, Devyani Deshpande, Carleton M Sherman, et al.
Page
of 21